Shanghai Medicilon Revenue

In the year 2024, Shanghai Medicilon had annual revenue of 1.04B CNY, down -24.01%. Shanghai Medicilon had revenue of 236.02M in the quarter ending December 31, 2024, with 29.37% growth.

Revenue

1.04B

Revenue Growth

-24.01%

P/S Ratio

3.69

Revenue / Employee

399.13K

Employees

2,600

Market Cap

3.83B

Revenue Chart

Revenue History

Fiscal Year End	Revenue	Change	Growth
Dec 31, 2024	1.04B	-327.89M	-24.01%
Dec 31, 2023	1.37B	-293.30M	-17.68%
Dec 31, 2022	1.66B	491.67M	42.12%
Dec 31, 2021	1.17B	501.31M	75.28%
Dec 31, 2020	665.96M	216.56M	48.19%
Dec 31, 2019	Pro	Pro	Pro
Dec 31, 2018	Pro	Pro	Pro
Dec 31, 2017	Pro	Pro	Pro
Dec 31, 2016	Pro	Pro	Pro
Dec 31, 2015	Pro	Pro	Pro

Revenue Definition

Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.

Full Definition

Related Stocks

Company Name	Revenue
Jiangsu Hengrui Medicine	29.19B
Shenzhen Mindray Bio-Medical Electronics	37.11B
WuXi AppTec	37.92B
Zhangzhou Pientzehuang Pharmaceutical.,	10.79B
Aier Eye Hospital Group	20.98B
Sichuan Biokin Pharmaceutical	5.82B
Shanghai United Imaging Healthcare	10.30B
Yunnan Baiyao Group Co.,Ltd	40.03B

Revenue Rankings